Stocks · Health care · Pharmaceutical Preparations

Q32 Bio Inc.

FIXX Clue Score74
United States Fiscal year ends December CIK 0001661998 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Isaac Manke
30 Jun 2026
Director
Exercised, kept
53,521
$2.80
$149.86K
Shelia M. Violette
15 Oct 2024
Chief Scientific Officer
Exercised, kept
6,000
$7.29
$43.74K
Shelia M. Violette
11 Oct 2024
Chief Scientific Officer
Exercised, kept
4,574
$3.12
$14.27K
Shelia M. Violette
8 Oct 2024
Chief Scientific Officer
Exercised, kept
13,300
$3.12
$41.50K
Richard J. Gregory
18 Nov 2019
Director
Exercised, kept
10,806
$0.03
$324.18

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 15
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 22
Sales at will 99
Transactions with no price 0
Shares from compensation/vesting 34,811,374
Sales filed before the plan box existed 81
History held since 29 Mar 2018